How does stem cell therapy treat hepatitis?

MSCs reduce hepatic inflammation, promote liver cell regeneration, reverse fibrosis, and modulate the immune response that contributes to liver damage. This helps restore healthy liver function.

Can stem cell therapy reverse liver damage from hepatitis?

MSC therapy can promote significant liver tissue repair and reduce fibrosis. While complete reversal depends on the extent of damage, many patients show measurable improvements in liver function tests and ultrasound findings.

Is stem cell therapy safe for hepatitis patients?

Yes. MSC therapy has an excellent safety profile for hepatitis patients. Our Wharton's jelly-derived stem cells are well-tolerated and do not pose risks of viral reactivation or immune complications.

Hepatitis Stem Cell Therapy in Istanbul, Turkey

Stem cell therapy for hepatitis and liver inflammation. MSC treatments repair liver damage, reduce hepatic inflammation, and help restore healthy liver function.

About Hepatitis Stem Cell Therapy in Istanbul

Stem cell therapy for hepatitis at StemCell Longevita in Istanbul helps repair liver damage caused by chronic hepatitis B and C infection. Our MSC treatments reduce hepatic inflammation, reverse fibrosis, and promote liver cell regeneration — restoring liver architecture and function even in patients with advanced hepatitis-related liver damage.

How Stem Cell Therapy Works for This Condition

Chronic hepatitis causes progressive liver inflammation, fibrosis, and eventual cirrhosis. MSCs reduce hepatic inflammation through anti-inflammatory cytokine release, inhibit fibrotic pathways by suppressing activated hepatic stellate cells, promote hepatocyte regeneration, and modulate the immune response to reduce ongoing liver damage. This regenerative approach complements antiviral therapy by repairing the damage already done to the liver.

Who Is a Candidate?

Patients with chronic hepatitis B or C (with or without active antiviral treatment), hepatitis-related liver fibrosis or cirrhosis, and those with persistently elevated liver enzymes despite viral suppression. MSC therapy works alongside antiviral medications and does not interfere with viral treatment regimens.

Treatment Process at StemCell Longevita

After review of viral load, liver function tests, and fibrosis staging, treatment involves systemic IV MSC infusion. The treatment is administered in our accredited hospital with full monitoring. Most patients stay 3-5 days in Istanbul.

Expected Results & Recovery

Improvements in liver function tests within 1-3 months. Fibrosis regression on follow-up elastography at 3-6 months. Patients report improved energy, better appetite, reduced right upper quadrant discomfort, and improved overall wellbeing. The regenerative effects complement ongoing antiviral therapy.

Why Choose Turkey for Treatment?

Istanbul's hepatology centers have extensive experience treating hepatitis patients from the Middle East, Central Asia, and Africa. Our regenerative protocols add a repair dimension to standard antiviral treatment at affordable costs.

Cost of Treatment

Hepatitis stem cell therapy from €6,950, including viral load assessment, liver evaluation, MSC infusion, hotel accommodation, VIP transfers, and 12-month hepatic monitoring.

Part of Our Liver & Metabolic Conditions Treatment Cluster

Liver & Metabolic Conditions — Treatment Cluster

Pillar: stem cell therapy for liver disease in Istanbul

Research & guides: MSC therapy for diabetes management in Turkey | stem cell treatment for liver cirrhosis and fibrosis in Istanbul

Frequently Asked Questions About Hepatitis Stem Cell Therapy

How does stem cell therapy treat hepatitis?: MSCs reduce hepatic inflammation, promote liver cell regeneration, reverse fibrosis, and modulate the immune response that contributes to liver damage. This helps restore healthy liver function.
Can stem cell therapy reverse liver damage from hepatitis?: MSC therapy can promote significant liver tissue repair and reduce fibrosis. While complete reversal depends on the extent of damage, many patients show measurable improvements in liver function tests and ultrasound findings.
Is stem cell therapy safe for hepatitis patients?: Yes. MSC therapy has an excellent safety profile for hepatitis patients. Our Wharton's jelly-derived stem cells are well-tolerated and do not pose risks of viral reactivation or immune complications.